Katolkar U, Surana S
Curr Protein Pept Sci. 2024; 25(10):753-779.
PMID: 38919003
DOI: 10.2174/0113892037307940240606075208.
Su L, Yang R, Sheng Y, Ullah S, Zhao Y, Shunjiayi H
Front Microbiol. 2024; 15:1369834.
PMID: 38756728
PMC: 11098135.
DOI: 10.3389/fmicb.2024.1369834.
Mesgari H, Esmaelian S, Nasiri K, Ghasemzadeh S, Doroudgar P, Payandeh Z
Cancers (Basel). 2023; 15(23).
PMID: 38067304
PMC: 10705512.
DOI: 10.3390/cancers15235600.
Brennan K, Espin-Perez A, Chang S, Bedi N, Saumyaa S, Shin J
Genome Med. 2023; 15(1):98.
PMID: 37978395
PMC: 10656821.
DOI: 10.1186/s13073-023-01236-w.
Liberale C, Soloperto D, Marchioni A, Monzani D, Sacchetto L
Int J Mol Sci. 2023; 24(16).
PMID: 37629093
PMC: 10454133.
DOI: 10.3390/ijms241612913.
Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database.
Li Y, Bi J, Pi G, He H, Li Y, Han G
Ann Transl Med. 2023; 11(4):163.
PMID: 36923087
PMC: 10009575.
DOI: 10.21037/atm-22-6481.
Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.
Kirtane K, St John M, Fuentes-Bayne H, Patel S, Mardiros A, Xu H
J Clin Med. 2022; 11(24).
PMID: 36555876
PMC: 9781632.
DOI: 10.3390/jcm11247259.
One hundred most-cited articles in head and neck surgery and analysis of female authorship.
Trent M, Michelle L, Roman K, Kim J, Haidar Y, Tjoa T
Head Neck. 2022; 45(1):42-58.
PMID: 36193849
PMC: 9742131.
DOI: 10.1002/hed.27210.
Integrative analysis of genomic and transcriptomic data of normal, tumour, and co-occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour initiation and progression.
Ghosh A, Das C, Ghose S, Maitra A, Roy B, Majumder P
J Pathol. 2022; 257(5):593-606.
PMID: 35358331
PMC: 9545831.
DOI: 10.1002/path.5900.
Recognizing Pattern and Rule of Mutation Signatures Corresponding to Cancer Types.
Chen L, Zhou X, Zeng T, Pan X, Zhang Y, Huang T
Front Cell Dev Biol. 2021; 9:712931.
PMID: 34513841
PMC: 8427289.
DOI: 10.3389/fcell.2021.712931.
Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma.
Kordbacheh F, Farah C
Cancers (Basel). 2021; 13(14).
PMID: 34298667
PMC: 8307423.
DOI: 10.3390/cancers13143453.
Genetic polymorphism of tumor necrosis factor alpha (TNF-α) and tumor necrosis factor beta (TNF-β) genes and risk of oral pre-cancer and cancer in North Indian population.
Gupta S, Nigam K, Srivastav R, Ahmad M, Mahdi A, Sanyal S
Oral Maxillofac Surg. 2021; 26(1):33-43.
PMID: 33779868
DOI: 10.1007/s10006-020-00929-5.
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
Warren E, Anil J, Castro P, Kemnade J, Suzuki M, Hegde M
Head Neck. 2021; 43(7):1983-1994.
PMID: 33660372
PMC: 10320663.
DOI: 10.1002/hed.26662.
Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
Schiavetto C, de Abreu P, von Zeidler S, Jesus L, Carvalho R, Cirino M
Mol Diagn Ther. 2020; 25(1):59-70.
PMID: 33245553
DOI: 10.1007/s40291-020-00502-6.
Evidence for hypoxia increasing the tempo of evolution in glioblastoma.
Grimes D, Jansen M, Macauley R, Scott J, Basanta D
Br J Cancer. 2020; 123(10):1562-1569.
PMID: 32848201
PMC: 7653934.
DOI: 10.1038/s41416-020-1021-5.
Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
Batta N, Pandey M
World J Surg Oncol. 2019; 17(1):198.
PMID: 31775759
PMC: 6882338.
DOI: 10.1186/s12957-019-1741-2.
p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.
Rodriguez-Ramirez C, Nor J
Crit Rev Oncog. 2018; 23(3-4):173-187.
PMID: 30311573
PMC: 6396309.
DOI: 10.1615/CritRevOncog.2018027353.
Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
Lohavanichbutr P, Zhang Y, Wang P, Gu H, Gowda G, Djukovic D
PLoS One. 2018; 13(9):e0204249.
PMID: 30235319
PMC: 6147497.
DOI: 10.1371/journal.pone.0204249.
Targeting PRPK and TOPK for skin cancer prevention and therapy.
Roh E, Lee M, Zykova T, Zhu F, Nadas J, Kim H
Oncogene. 2018; 37(42):5633-5647.
PMID: 29904102
PMC: 6195829.
DOI: 10.1038/s41388-018-0350-9.
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.
Manterola L, Aguirre P, Larrea E, Arestin M, Gaafar A, Elorriaga K
Sci Rep. 2018; 8(1):6613.
PMID: 29700339
PMC: 5919930.
DOI: 10.1038/s41598-018-24780-7.